Valuation: Genex Pharmaceutical, Inc.

Market Cap 268K 232K 216K 198K 373K 25.48M 379K 2.54M 996K 12.77M 1.01M 983K 42.21M P/E 2006
3.75x
P/E 2007 15.1x
Enterprise Value 413K 357K 333K 306K 575K 39.26M 584K 3.91M 1.53M 19.68M 1.55M 1.52M 65.06M EV / Sales 2006
0.95x
EV / Sales 2007 1.6x
Free-Float
99.62%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 72 -
Director of Finance/CFO 72 23/02/2010
Director TitleAgeSince
Chairman 72 23/02/2010
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-39.83% - - 1.78K
+0.47%+4.09%-10.21%+20.08% 130B
+1.37%-3.93%-16.97%+0.27% 12.63B
+5.28%+7.98%+112.66%+140.73% 10.61B
+2.59%-3.43%-42.66%-67.38% 4.7B
+2.93%+3.12%-24.17%+41.20% 2.7B
+2.16%+19.82%-23.98%-75.44% 1.74B
+2.82%+0.80%-15.13%-12.55% 1.69B
+2.16%-0.93%-33.76%-28.67% 1.66B
Average +1.69%+3.66%-6.78%+2.28% 20.72B
Weighted average by Cap. +1.01%+3.66%-4.44%+22.34%

Financials

2006 2007
Net sales 2.44M 2.11M 1.97M 1.81M 3.4M 232M 3.45M 23.11M 9.07M 116M 9.16M 8.96M 385M 3.24M 2.8M 2.61M 2.4M 4.51M 308M 4.58M 30.68M 12.04M 154M 12.16M 11.89M 511M
Net income 619K 535K 500K 459K 863K 58.91M 876K 5.87M 2.3M 29.53M 2.32M 2.27M 97.61M 343K 296K 277K 254K 477K 32.6M 485K 3.25M 1.27M 16.34M 1.29M 1.26M 54.02M
Net Debt -0.19 -0.17 -0.16 -0.14 -0.27 -18.29 -0.27 -1.82 -0.71 -9.17 -0.72 -0.71 -30.31 0.14 0.13 0.12 0.11 0.2 13.79 0.21 1.37 0.54 6.91 0.54 0.53 22.84
Logo Genex Pharmaceutical, Inc.
Genex Pharmaceutical Inc is a company primarily engaged in the provision of bone grafting products and services. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The Company distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.
Employees
-